Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of zileuton may be an effective way to prevent
lung cancer in patients who have bronchial dysplasia.
PURPOSE: Randomized phase II trial to study the effectiveness of zileuton in preventing lung
cancer in patients who have bronchial dysplasia.